prostate header graphic
Prostate Problem Guide

BPH Affects More Than Half Of All Men Above The Age Of 60

BPH stands for benign prostatic hyperplasia (sometimes also called benign prostatic hypertrophy) and is a condition that will affect one man in every two by the age of 60, rising to nine out of every ten men by the age of 80. So what is it?

Well, in plain language, having BPH simply means that you are suffering from a swollen or enlarged prostate.

The prostate, which is situated just below the bladder and in front of the rectum, starts life at about the size of a pea and then grows rapidly during puberty to reach the size of a walnut by a man's early twenties. It then continues to grow very slowly normally throughout life. In many cases however the inner cells of the prostrate begin to show signs of abnormal growth and the prostate gland becomes enlarged to the point at which it may start to interfere with surrounding tissue and organs. At this point it is important to state that this cell growth is confined to the inner cells of the prostate and is not, and should not be confused with, prostate cancer.

The prostate gland is sometimes described as being "donut" shaped with part of the gland being wrapped around the urethra, which carries urine from the bladder out of the body. As the prostate gland enlarges it begins to pinch the urethra causing problems with urinating. This is usually the first sign that you may be suffering from BPH.

Some information from the prostate cancer glossary:

CELL-MEDIATED IMMUNITY: immunity dependent upon T-cells' recognition of an antigen and their subsequent destruction of cells bearing the antigen.

FROZEN SECTION: a technique in which removed tissue is frozen, cut into thin slices, and stained for microscopic examination; a pathologist can rapidly complete a frozen section analysis, and for this reason, it is commonly used during surgery to quickly provide the surgeon with vital information such as a preliminary pathologic opinion of the presence or absence of prostate cancer (usually in the pelvic lymph nodes).

LUTEINIZING HORMONE RELEASING HORMONE (LHRH): a hormone responsible for stimulating the production of testosterone in the body by interacting with the LHRH receptor to release LH which in turn stimulates cells in the testicles (Leydig cells) to make testosterone; luteinizing hormone-releasing hormone is also known as GnRH or gonadotrophin-releasing hormone.

RESORPTION: loss of bone through increased breakdown via osteoclasts or other mechanism causing a reduction in bone mass.

As time progresses you may experience a range of problems including difficulty in urinating (problems both starting and stopping the flow of urine), a frequent and urgent need to urinate, a feeling that your bladder is still full even after you have urinated and dribbling after you have finished urinating.

Although BPH is very common it need not necessarily present a problem and for many men the symptoms are so slight they really don't notice it at all, while for other men the problems are relatively minor and they simply don't worry about it. For a significant number of men however the symptoms can be sufficient to warrant one of a range of BPH treatments, usually starting with one or more of a variety of BPH drugs and moving on to surgery if necessary.

The most important thing to remember is that if you start to experience BPH symptoms then the chances are that you are suffering from BPH. This may not however be the case and there are a range of other problems that can produce the same or similar signs.

So, whether it worries you or not, it's always a good idea to check with your doctor if you start to develop BPH symptoms just to be on the safe side.

Further information on bph:

Urologix Announces Three Events at the 107th Annual Meeting of the American ... - NASDAQ


Urologix Announces Three Events at the 107th Annual Meeting of the American ...
NASDAQ
Sponsor of Expert Panel Lecture on In-Office BPH Therapies, Moderated by Dr. Claus Roehrborn Presentation of Cooled ThermoTherapy™ (CTT) Clinical Outcomes for Improving Nocturia by Dr. Lori Lerner MINNEAPOLIS, May 14, 2012 (GLOBE NEWSWIRE) -- Urologix ...

and more »

Urologix Announces Three Events at the 107th Annual Meeting of the American ... - MarketWatch (press release)


Urologix Announces Three Events at the 107th Annual Meeting of the American ...
MarketWatch (press release)
May 14, 2012 (GlobeNewswire via COMTEX) -- -- Sponsor of Expert Panel Lecture on In-Office BPH Therapies, Moderated by Dr. Claus Roehrborn -- Presentation of Cooled ThermoTherapy(TM) (CTT) Clinical Outcomes for Improving Nocturia by Dr. Lori Lerner ...

and more »

Nymox NX-1207 Symposium at American Urological Association Annual Meeting May ... - MarketWatch (press release)


Nymox NX-1207 Symposium at American Urological Association Annual Meeting May ...
MarketWatch (press release)
HASBROUCK HEIGHTS, NJ, May 16, 2012 (GlobeNewswire via COMTEX) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce a symposium and panel discussion on NX-1207, the Company's Phase 3 drug for benign prostatic hyperplasia (BPH), ...
NYMOX PHARMACEUTICAL CORPORATION : Nymox NX-1207 Symposium at American ...4-traders

all 4 news articles »